COMI, Cristoforo
 Distribuzione geografica
Continente #
EU - Europa 5.503
NA - Nord America 5.019
AS - Asia 3.712
SA - Sud America 803
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 1
Totale 15.193
Nazione #
US - Stati Uniti d'America 4.881
IE - Irlanda 1.501
SG - Singapore 1.470
DE - Germania 821
IT - Italia 766
HK - Hong Kong 681
CN - Cina 666
BR - Brasile 629
SE - Svezia 617
UA - Ucraina 494
RU - Federazione Russa 459
VN - Vietnam 379
FI - Finlandia 305
IN - India 147
GB - Regno Unito 131
FR - Francia 121
KR - Corea 89
CA - Canada 88
BJ - Benin 78
AR - Argentina 69
ID - Indonesia 66
PL - Polonia 48
BD - Bangladesh 41
EC - Ecuador 41
CZ - Repubblica Ceca 39
JP - Giappone 39
NL - Olanda 38
MX - Messico 36
AT - Austria 35
ZA - Sudafrica 34
IR - Iran 30
ES - Italia 29
TR - Turchia 28
BE - Belgio 27
LT - Lituania 22
CO - Colombia 18
GR - Grecia 18
PY - Paraguay 18
IQ - Iraq 11
CL - Cile 10
MA - Marocco 10
SA - Arabia Saudita 10
EU - Europa 9
IL - Israele 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
VE - Venezuela 7
UY - Uruguay 6
KW - Kuwait 5
NP - Nepal 5
PE - Perù 5
PK - Pakistan 5
AL - Albania 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LV - Lettonia 4
TN - Tunisia 4
UZ - Uzbekistan 4
DK - Danimarca 3
DZ - Algeria 3
PH - Filippine 3
SN - Senegal 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
LK - Sri Lanka 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SV - El Salvador 1
TW - Taiwan 1
Totale 15.193
Città #
Dublin 1.499
Jacksonville 858
Hong Kong 675
Singapore 441
Dearborn 435
Beijing 333
Ashburn 307
Chandler 213
Los Angeles 203
Wilmington 200
Moscow 186
Lawrence 180
Princeton 180
Ho Chi Minh City 132
San Mateo 109
Buffalo 101
Ann Arbor 98
Munich 98
Piemonte 95
Milan 87
Seoul 86
New York 85
Cotonou 78
Andover 72
Helsinki 71
Boardman 68
Hanoi 67
Novara 66
São Paulo 66
Dallas 53
Dong Ket 52
Turin 49
Bremen 45
Rome 45
Santa Clara 42
Brno 38
Redondo Beach 38
Nuremberg 36
Tokyo 35
Monmouth Junction 34
Toronto 34
Warsaw 34
Woodbridge 34
Denver 33
Jakarta 33
Houston 30
Grafing 29
Hefei 29
Chennai 28
Turku 27
Brooklyn 26
Brussels 26
Torino 26
Amsterdam 25
Falkenstein 25
Frankfurt am Main 25
London 25
Orem 25
Strasbourg 25
Nanjing 24
Johannesburg 23
Poplar 23
Düsseldorf 22
Seattle 22
Boston 21
Montreal 21
Stockholm 21
Atlanta 20
Guayaquil 20
Phoenix 20
Manchester 19
Chicago 18
Mülheim 18
Tianjin 18
Belo Horizonte 17
Norwalk 17
Rio de Janeiro 17
Ankara 16
Mumbai 16
Fairfield 15
Kunming 15
Mexico City 15
Vienna 15
Alessandria 14
Da Nang 14
Porto Alegre 13
Thái Bình 13
Vercelli 13
Assago 12
Nanchang 12
Ardabil 11
Jinan 11
Ottawa 11
Quito 11
Zanjan 11
Leawood 10
Wroclaw 10
Brasília 9
Dhaka 9
Espoo 9
Totale 8.741
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 205
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report 163
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study 154
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Change over time of COVID-19 hospital presentation in Northern Italy 132
Impaired visual inhibition in migraine with aura. 128
Cortical visuomotor interactions in Freezing of Gait: A TMS approach 119
Anti-cytokine autoantibodies in autoimmune diseases 114
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 111
Insights into the protective role of immunity in neurodegenerative disease 111
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 111
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 107
Kappa free light chains could predict early disease course in multiple sclerosis 107
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 104
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 103
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 102
A91V variation of the perforin gene in patients with multiple sclerosis 101
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 101
ICOS gene haplotypes correlate with multiple sclerosis development and progression 100
Phenotypic heterogeneity of movement disorders due to intracranial calcifications with or without SLC20A2 mutations 98
Calcium and glutamate involvement in activation of multiple sclerosis patient lymphocytes 97
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 97
Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients 96
Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs 96
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 95
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 95
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 94
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies 93
Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients 93
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 92
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 91
Circulating extracellular vesicles in subarachnoid hemorrhage patients: characterization and cellular effects 90
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 90
Advances in Neuroimmunology: From Bench to Bedside 90
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 90
A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition 89
A case of progressive multifocal leukoencephalopathy after autologous bone marrow transplantation successfully treated with mirtazapine and cidofovir 89
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 87
Intrathecal kappa free light chains as markers for multiple sclerosis 87
An investigation of the role of common and rare variants in a large italian multiplex family of multiple sclerosis patients 87
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population 87
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 85
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 84
Intensive Rehabilitation Treatment in Early Parkinson's Disease: A Randomized Pilot Study With a 2-Year Follow-up 84
IV lacosamide: Report of two cases of successful treatment of refractory status epilepticus [Utilizzo di lacosamide ev: Esperienza in due casi di stato di male epilettico refrattario] 84
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk 84
Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence 84
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 84
Complex pattern of convulsive syncope in glossopharyngeal neuralgia: video/EEG report and short review 83
Short-term videoEEG: Review of a 3-year experience [Short-term videoEEG: Studio retrospettivo di 3 anni di esperienza clinica] 83
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy 83
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 82
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 82
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know? 82
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 82
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 81
Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2019) 178(1) (262), (S0092867419306798), (10.1016/j.cell.2019.06.016)) 81
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 80
A novel genetic prediction score in myoclonus-dystonia 79
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 79
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 79
Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis 78
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 78
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 78
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 77
CD4+ T-Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson’s Disease 77
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 77
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 76
Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients: A Randomized Controlled Trial With 1-Year Follow-up 76
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 76
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 74
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 73
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 73
Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. 73
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature 73
Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy 72
The impact of osteopontin gene variations on multiple sclerosis development and progression 72
Intensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients: A Randomized Study 72
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens. 72
Changes of cortical excitability due to sleep deprivation: A transcranical magnetic stimulation study [Deprivazione di sonno ed eccitabilita corticale: Studio con stimolazione magnetica transcranica] 70
Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy 70
Variations of the perforin gene in patients with multiple sclerosis 69
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis 69
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients 69
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 69
Osteopontin is increased in the cerebrospinal fluid of patients with early Alzheimer's disease and its levels correlate with cognitive deterioration 68
Immunity and inflammation in neurodegenerative diseases. 68
Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage 68
Fahr's disease: heterogeneous clinical manifestations of an under-recognized disease 68
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial. 68
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 68
Immunohistochemical signals of apoptotic pathways in several types of meningioma 68
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease 68
IP-10 haplotypes and multiple sclerosis: association and correlation with clinical course 67
Susac Syndrome: an uncommon cause of impaired vision 67
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 67
Rituximab treated CIDP: a retrospective study 66
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 66
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 65
Defective T cell Fas function in patients with multiple sclerosis 65
Totale 8.760
Categoria #
all - tutte 93.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021667 0 0 0 0 0 63 170 10 169 15 180 60
2021/20221.236 69 36 131 137 57 18 127 22 120 47 178 294
2022/20232.607 205 138 136 27 118 183 85 101 1.448 18 98 50
2023/20241.203 77 52 114 48 203 23 210 70 27 13 108 258
2024/20252.953 65 47 200 96 63 217 299 213 741 208 249 555
2025/20264.037 443 339 676 1.476 983 120 0 0 0 0 0 0
Totale 15.491